Your browser doesn't support javascript.
loading
Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Leineweber, Can G; Rabehl, Miriam; Pietzner, Anne; Rohwer, Nadine; Rothe, Michael; Pech, Maciej; Sangro, Bruno; Sharma, Rohini; Verslype, Chris; Basu, Bristi; Sengel, Christian; Ricke, Jens; Schebb, Nils Helge; Weylandt, Karsten-H; Benckert, Julia.
Afiliação
  • Leineweber CG; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.
  • Rabehl M; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.
  • Pietzner A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Rohwer N; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.
  • Rothe M; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.
  • Pech M; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.
  • Sangro B; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.
  • Sharma R; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.
  • Verslype C; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.
  • Basu B; Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Sengel C; Lipidomix, Berlin, Germany.
  • Ricke J; Department of Radiology and Nuclear Medicine, Otto-von-Guericke University, Magdeburg, Germany.
  • Schebb NH; Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain.
  • Weylandt KH; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Benckert J; Department of Digestive Oncology, University Hospitals Leuven, Leuven, Belgium.
Front Pharmacol ; 14: 1354581, 2023.
Article em En | MEDLINE | ID: mdl-38273836
ABSTRACT
[This corrects the article DOI 10.3389/fphar.2023.1124214.].
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article